Matthias Gaestel

21PUBLICATIONS
65CO-AUTHORS
Epigenetics (incl. genome methylation and epigenomics)Medical infection agents (incl. prions)Molecular targetsCancer cell biologyMedical devices
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Jul 13, 2026
Septin7 is essential in early hematopoiesis, but redundant at later stages.

|Apr 14, 2026
MK2/p38/p53 Suppress Basal IL-1β and Non-Canonical NF-κB Signaling in Macrophages.

Sarah M Herr, Diana Stalkopf, Sofie Padaszus

|Apr 14, 2025
Targeting the TLK1-MK5 Axis Suppresses Prostate Cancer Metastasis.

Damilola Olatunde, Omar Coronel Franco, Matthias Gaestel

|Aug 08, 2024
Regulation of Zfp36 by ISGF3 and MK2 restricts the expression of inflammatory cytokines during necroptosis stimulation.

Sahil Yadav, Rayan El Hamra, Norah A Alturki

|Aug 29, 2023
Targeting Aggressive B-cell Lymphomas through Pharmacological Activation of the Mitochondrial Protease OMA1.

Adrian Schwarzer, Matheus Oliveira, Marc-Jens Kleppa

|Jul 26, 2023
5-Iodotubercidin sensitizes cells to RIPK1-dependent necroptosis by interfering with NFκB signaling.

Chanchal Chauhan, Andreas Kraemer, Stefan Knapp

Pageof 4

Frequent Collaborators

5 joint publications

Manoj B Menon

2 joint publications

Norman Häfner

2 joint publications

Bruce G Allen

2 joint publications

Anneke Dörrie